ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Form 10-K Annual Reports
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARWR
CIK: 879407
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerEmad Fareed
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0001242615-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | FORM 4 | 0001250379-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001628280-26-057774 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001628280-26-057767 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003461 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0000879407-26-000058 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0000879407-26-000057 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100121-26-000891 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002186 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0002141314-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-06-17 | 2026-06-15 | FORM 3 | 0002141314-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-12 | 8-K | 0000879407-26-000050 | View SEC Doc Filr Page |
| 144/A | 2026-05-19 | — | 144/A Filing | 0001628280-26-036528 | View SEC Doc Filr Page |
| 144/A | 2026-05-19 | — | 144/A Filing | 0001628280-26-036522 | View SEC Doc Filr Page |
| 144/A | 2026-05-19 | — | 144/A Filing | 0001628280-26-036511 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0001767584-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-05-12 | — | 144 Filing | 0001628280-26-034153 | View SEC Doc Filr Page |
| S-8 | 2026-05-07 | — | S-8 | 0001193125-26-212473 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0000879407-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0000879407-26-000045 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-06 | — | SCHEDULE 13G Filing | 0000315066-26-001120 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002100119-26-000162 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-28 | — | SCHEDULE 13G Filing | 0002100121-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-04-24 | 2026-04-22 | FORM 4 | 0000879407-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-04-24 | 2026-04-23 | FORM 4 | 0001830755-26-000007 | View SEC Doc Filr Page |